Immunocore Holdings plc
IMCR · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $1,831,167 | $1,578,226 | $1,486,072 | $1,474,735 |
| - Cash | $498,413 | $487,933 | $476,845 | $455,731 |
| + Debt | $43,275 | $436,464 | $433,995 | $432,722 |
| Enterprise Value | $1,376,029 | $1,526,757 | $1,443,222 | $1,451,726 |
| Revenue | $103,693 | $97,964 | $93,881 | $84,052 |
| % Growth | 5.8% | 4.3% | 11.7% | – |
| Gross Profit | $103,180 | $96,924 | $93,050 | $83,722 |
| % Margin | 99.5% | 98.9% | 99.1% | 99.6% |
| EBITDA | $4,145 | -$6,399 | $9,963 | -$15,274 |
| % Margin | 4% | -6.5% | 10.6% | -18.2% |
| Net Income | $785 | -$10,300 | $5,023 | -$23,771 |
| % Margin | 0.8% | -10.5% | 5.4% | -28.3% |
| EPS Diluted | 0.016 | -0.21 | 0.097 | -0.47 |
| % Growth | 107.4% | -316.3% | 120.7% | – |
| Operating Cash Flow | -$4,456 | $25,964 | $435 | -$13,951 |
| Capital Expenditures | -$748 | -$414 | -$298 | -$3,584 |
| Free Cash Flow | -$5,204 | $25,550 | $137 | -$17,535 |